BRIEF published on 12/13/2024 at 08:10, 1 year 5 months ago Nyxoah lance la thérapie Genio® en Angleterre Apnée Obstructive Du Sommeil Nyxoah SA Lancement Sur Le Marché Thérapie Genio® Service National De Santé D'Angleterre
BRIEF published on 12/13/2024 at 08:10, 1 year 5 months ago Nyxoah Launches Genio® Therapy in England NHS England Obstructive Sleep Apnea Nyxoah SA Market Launch Genio® Therapy
PRESS RELEASE published on 12/13/2024 at 08:05, 1 year 5 months ago Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England Nyxoah announces commercial launch of Genio Innovative Therapy in England with successful implants at UCLH. Genio system covered under NHS SSDP for OSA patients Nyxoah Genio Innovative Therapy England OSA
BRIEF published on 11/06/2024 at 22:10, 1 year 6 months ago Nyxoah publie ses résultats financiers du troisième trimestre 2024 Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF published on 11/06/2024 at 22:10, 1 year 6 months ago Nyxoah Reports Third Quarter 2024 Financial Results Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE published on 11/06/2024 at 22:05, 1 year 6 months ago Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026 Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF published on 10/08/2024 at 14:05, 1 year 7 months ago Nyxoah Secures $27 Million in At-the-Market Offering Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
BRIEF published on 10/08/2024 at 14:05, 1 year 7 months ago Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 7 months ago Nyxoah Raises $27 Million through its At-the-Market Offering Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF published on 09/27/2024 at 22:35, 1 year 7 months ago Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024 Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
Published on 05/27/2026 at 02:10, 5 hours ago Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 5 hours 25 minutes ago Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 6 hours 45 minutes ago Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 8 hours 55 minutes ago LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/26/2026 at 22:01, 9 hours 9 minutes ago Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI
Published on 05/27/2026 at 06:00, 1 hour 10 minutes ago Verve Group Reports Solid Organic Growth in the First Quarter, Along with Strong Operating Performance and Significant Cash Flow Growth
Published on 05/26/2026 at 18:50, 12 hours 19 minutes ago The AI Gold Rush Is Running Into a Margin Problem
Published on 05/26/2026 at 18:30, 12 hours 40 minutes ago H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:45, 13 hours 25 minutes ago FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN
Published on 05/26/2026 at 17:30, 13 hours 40 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 18:39, 12 hours 30 minutes ago Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Published on 05/26/2026 at 18:39, 12 hours 30 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 13 hours 25 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 17:45, 13 hours 25 minutes ago EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Published on 05/26/2026 at 17:40, 13 hours 30 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.
